IllumiCare, Inc.

Analysis of IllumiCare, Inc.

IllumiCare, Inc. is a Health Care and Information Technology startup founded in 2014 in the United States. The company offers a platform of apps, known as Smart Ribbons, which provide real-time patient-specific and cost and patient risk data to clinicians. Their latest Series B investment of $3.70M took place on 17 July 2017.

The Smart Ribbons are designed as a non-intrusive overlay on electronic medical record (EMR) screens, offering information without requiring EMR integration. They empower clinicians by providing relevant data at the point of care, influencing key areas such as medications, labs, radiology, and observational status.

One key strength of Smart Ribbons is their EMR-agnostic nature, making them adaptable for use in any hospital. Leveraging existing HL7 feeds and incorporating data from third-party sources, they enhance the EMR while respecting existing authentication and permission infrastructure.

Moreover, the company highlights that the Smart Ribbons are not just a reformatting of data, do not disrupt clinical workflow, and are not proscriptive, addressing common concerns in healthcare technology adoption.

With their value proposition aimed at both clinical and financial efficiency, Smart RibbonsTM offer a powerful tool for physician alliances and Accountable Care Organizations (ACOs) to drive cost savings and provide measurable reductions in various expenses.

Overall, IllumiCare, Inc. presents a compelling solution with the potential to significantly impact healthcare delivery and cost management. Their innovative approach, combined with the recent infusion of Series B funding, positions them well for further growth and market penetration.